modafinil has been researched along with Recrudescence in 5 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Modafinil or armodafinil (ar/mod) augmentation of antipsychotic medication in schizophrenia patients may be considered with a view to reduce negative symptoms associated with the illness or excessive daytime drowsiness due to any cause." | 3.81 | Delayed drug interactions in psychiatry: armodafinil and risperidone as a potential case in point. ( Andrade, C, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, C | 1 |
| Shearer, J | 1 |
| Darke, S | 1 |
| Rodgers, C | 1 |
| Slade, T | 1 |
| van Beek, I | 1 |
| Lewis, J | 1 |
| Brady, D | 1 |
| McKetin, R | 1 |
| Mattick, RP | 1 |
| Wodak, A | 1 |
| IsHak, WW | 1 |
| Davis, M | 1 |
| Jeffrey, J | 1 |
| Balayan, K | 1 |
| Pechnick, RN | 1 |
| Bagot, K | 1 |
| Rapaport, MH | 1 |
| Hester, R | 1 |
| Lee, N | 1 |
| Pennay, A | 1 |
| Nielsen, S | 1 |
| Ferris, J | 1 |
| Wolf, J | 1 |
| Fiedler, U | 1 |
| Anghelescu, I | 1 |
| Schwertfeger, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomised Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence[NCT00123370] | Phase 2 | 87 participants (Anticipated) | Interventional | 2006-07-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for modafinil and Recrudescence
| Article | Year |
|---|---|
The role of dopaminergic agents in improving quality of life in major depressive disorder.
Topics: Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Depressive Disorder, Major; Dopa | 2009 |
2 trials available for modafinil and Recrudescence
| Article | Year |
|---|---|
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Australia; Benzhydryl Compounds; Central Nervous System Stimul | 2009 |
The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Attention; Benzhydryl Compounds; Central Nervous System Stimul | 2010 |
2 other studies available for modafinil and Recrudescence
| Article | Year |
|---|---|
Delayed drug interactions in psychiatry: armodafinil and risperidone as a potential case in point.
Topics: Antipsychotic Agents; Benzhydryl Compounds; Drug Interactions; Drug Synergism; Humans; Modafinil; Re | 2015 |
Manic switch in a patient with treatment-resistant bipolar depression treated with modafinil.
Topics: Benzhydryl Compounds; Bipolar Disorder; Drug Resistance; Female; Humans; Middle Aged; Modafinil; Rec | 2006 |